| UHC Medicaid Medical & Drug | Ustekinumab – Community Plan Medical Benefit Drug Policy | 2026-04-01 |
| UHC Medicaid Medical & Drug | Vyepti® (Eptinezumab-Jjmr) – Community Plan Medical Benefit Drug Policy | 2026-04-01 |
| UHC Medicaid Medical & Drug | Vyjuvek® (Beramagene Geperpavec-Svdt) – Community Plan Medical Benefit Drug Policy | 2026-04-01 |
| UHC Medicaid Medical & Drug | White Blood Cell Colony Stimulating Factors – Community Plan Medical Benefit Drug Policy | 2026-04-01 |
| UHC Medicaid Medical & Drug | Whole Exome and Whole Genome Sequencing (Non-Oncology Conditions) – Community Plan Medical Policy | 2026-04-01 |
| UHC Medicaid Medical & Drug | Xiaflex® (Collagenase Clostridium Histolyticum) – Community Plan Medical Benefit Drug Policy | 2026-04-01 |
| UHC Medicaid Medical & Drug | Xolair® (Omalizumab) – Community Plan Medical Benefit Drug Policy | 2026-04-01 |
| UHC Medicaid Medical & Drug | Zolgensma® (Onasemnogene Abeparvovec-Xioi) – Community Plan Medical Benefit Drug Policy | 2026-04-01 |
| Medicare CGS | Knee Orthoses - Policy Article (52465) | 2026-04-01 |
| Medicare NGS | Billing and Coding: Cervical Fusion (59632) | 2026-04-01 |